1. Home
  2. MBBC vs BOLD Comparison

MBBC vs BOLD Comparison

Compare MBBC & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBBC
  • BOLD
  • Stock Information
  • Founded
  • MBBC 1902
  • BOLD 2018
  • Country
  • MBBC United States
  • BOLD United States
  • Employees
  • MBBC N/A
  • BOLD N/A
  • Industry
  • MBBC Banks
  • BOLD
  • Sector
  • MBBC Finance
  • BOLD
  • Exchange
  • MBBC Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • MBBC 29.3M
  • BOLD 24.4M
  • IPO Year
  • MBBC N/A
  • BOLD 2024
  • Fundamental
  • Price
  • MBBC $10.03
  • BOLD $1.14
  • Analyst Decision
  • MBBC
  • BOLD Buy
  • Analyst Count
  • MBBC 0
  • BOLD 3
  • Target Price
  • MBBC N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • MBBC 10.2K
  • BOLD 278.2K
  • Earning Date
  • MBBC 08-22-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • MBBC N/A
  • BOLD N/A
  • EPS Growth
  • MBBC 103.56
  • BOLD N/A
  • EPS
  • MBBC 0.22
  • BOLD N/A
  • Revenue
  • MBBC $6,591,743.00
  • BOLD N/A
  • Revenue This Year
  • MBBC N/A
  • BOLD N/A
  • Revenue Next Year
  • MBBC N/A
  • BOLD N/A
  • P/E Ratio
  • MBBC $45.54
  • BOLD N/A
  • Revenue Growth
  • MBBC N/A
  • BOLD N/A
  • 52 Week Low
  • MBBC $6.38
  • BOLD $1.00
  • 52 Week High
  • MBBC $12.00
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • MBBC N/A
  • BOLD N/A
  • Support Level
  • MBBC N/A
  • BOLD N/A
  • Resistance Level
  • MBBC N/A
  • BOLD N/A
  • Average True Range (ATR)
  • MBBC 0.00
  • BOLD 0.00
  • MACD
  • MBBC 0.00
  • BOLD 0.00
  • Stochastic Oscillator
  • MBBC 0.00
  • BOLD 0.00

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: